Table 1.
Baseline characteristics of patients with liver cancer (N = 504).
| Patients (504) | |
|---|---|
| Sex, n (%) | |
| Men | 386 (76.6) |
| Women | 118 (23.4) |
| Age (year) | 56.63 ± 12.06 |
| Tumor stage, n (%) | |
| I | 77 (15.3) |
| II | 93 (18.5) |
| III | 102 (20.2) |
| IV | 232 (45.9) |
| Surgery, n (%) | |
| Yes | 204 (40.5) |
| No | 300 (59.5) |
| Chemotherapy, n (%) | |
| Yes | 86 (17.1) |
| No | 419 (83.0) |
| Radiotherapy, n (%) | |
| Yes | 18 (3.6) |
| No | 487 (96.4) |
| Liver cirrhosis, n (%) | |
| Yes | 107 (21.2%) |
| No | 397 (78.8%) |
| Smoking n (%) | |
| Yes | 122 (24.2) |
| No | 106 (21.0) |
| Other | 276 (54.8) |
| Alcohol n (%) | |
| Yes | 130 (25.8) |
| No | 374 (74.2) |
| BMI (kg/m2) | 22.37 ± 3.23 |
| Total protein (g/L) | 68.36 ± 8.09 |
| Albumin (g/L) | 37.02 ± 6.14 |
| TSF (mm) | 14.00 [10.00, 20.00] |
| HGS (kg) | 26.30 [20.60, 32.00] |
| CRP (mg/L) | 16.82 [4.40, 34.70] |
| AST (U/L) | 40.00 [27.00, 75.40] |
| ALT (U/L) | 35.00 [23.10, 58.80] |
Continuous variables are presented as mean ± standard deviation (SD). Meanwhile, TSF, HGS, CRP, AST and ALT are presented as the median (interquartile range). Categorical variables are presented as numbers and percentages. Differences in normally and non-normally distributed baseline characteristics were compared using the chi-square test or t-test and Wilcoxon rank sum test, respectively. TSF, triceps skinfold thickness; HGS, handgrip strength; BMI, body mass index; CRP, C reactive protein; AST, aspartate aminotransferase; ALT, Alanine aminotransferase.